$NEXT

Next Biometrics Reports Wider Q1 Loss

Next Biometrics (NEXT.OL) reported a wider Q1 loss for the quarter ended March 31, citing higher costs of materials and other operating expenses. Net loss attributable to owners rose to NOK 32.32m from NOK 19.87m; loss per share increased to NOK 0.26 from NOK 0.17. EBITDA loss widened to NOK 30.32m. Shares closed at NOK 0.99, down 13.16% on Thursday.

Original reporting
Published May 29, 2026, 2:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 2:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$NEXT
Bearish
medium confidence
Mentioned
$NEXT
Relevance
8/10
alphai data visualization · based on rttnews.com
Decision brief

The 30-second read

$NEXTBearishMed
01

Why it matters

Higher cost of materials and other operating expenses drove the larger net loss and EBITDA loss, with shares falling sharply on the day of the report.

02

Market read

The print provides fresh quarterly datapoints (net loss, EPS, EBITDA) and a same-day equity reaction, informing near-term risk pricing.

03

What to watch

The article doesn’t break out revenue trends, cash burn, guidance, or balance-sheet liquidity—those could offset the earnings optics if funding runway is strong.

Relevance 8/10Novelty 8/10Timing: after the Q1 results print (shares down on the day)

Background

Next Biometrics (Norway) released first-quarter results for the period ended March 31, reporting wider losses versus the prior year.

Company-level read

Ticker impact

$NEXTBearishMedium confidence
Context

Next Biometrics reported a wider Q1 loss, with higher materials costs and operating expenses driving EBITDA and net loss deterioration.

Expected impact

Bearish bias for the next sessions as investors reprice ongoing cost headwinds; downside risk if margins continue to deteriorate.

Evidence & confidence

The article provides concrete Q1 P&L metrics (net loss, EPS, EBITDA loss) and attributes the worsening to higher costs, alongside a sharp single-day share drop.

Market effects

Biometrics/health-tech names with similar cost structures may face read-across selling if investors generalize the materials/opex pressure.

Potential negative sentiment spillover within Oslo-listed small/mid-cap growth/biotech complex.

Limited beyond the company unless broader biometrics peers also show margin compression.

Counterpoint

Adjusted EBITDA loss was roughly flat year-over-year, suggesting the headline net loss may be influenced by non-cash or below-the-line items rather than core operating collapse.

Key entities

  • Next Biometrics

    Norwegian biometrics company reporting wider Q1 loss due to higher materials and operating expenses.

Related articles

$NEXTMed

NextDecade (NEXT) Q2 2026 Earnings Call Transcript

NextDecade (NEXT) reported Q2 2026 progress on Rio Grande LNG construction. Trains 1 and 2 were 74% complete, with first gas expected in late 2026 and Train 1 LNG in 1H 2027. Train 6 permitting has a final EIS due June 25, 2027. The company completed a debt recap using a $1B term loan and $3.5B secured notes.

$NEXTMed

NextDecade (NEXT) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Megan Light Chairman and Chief Executive Officer - Matt Schatzman Chief Financial Officer - John Zuklic TAKEAWAYS Phase 1 Construction Progress -- Trains 1 and 2 reached 74% completion as of June 2026, with construction specific activities at almost 60% and engineering and procurement nearing completion.

$NEXTMed

NextDecade Corp (NEXT) (Q2 2026) Earnings Call Highlights: Rio Grande LNG Progress

Q: Can you walk us through the key commissioning milestones for Rio Grande LNG over the next two quarters, and when should we expect updated guidance on first LNG? A: Matt Schotzman, Chairman and CEO: Key milestones include the completion of the LNG tank and the Bayrunner pipeline. We are working with Bechtel on the most efficient commissioning sequence. We expect to provide narrower guidance on first LNG timing in the fourth quarter of 2026.

$NEXTMed

UAE Business: XRG boosts US LNG position with second Rio Grande stake buy

XRG, Abu Dhabi National Oil Company’s investment arm, says it completed buying an additional 7.6% equity interest in Rio Grande LNG Trains 4 and 5 at Brownsville, Texas, from a GIP acquisition vehicle. XRG now has stakes across all five trains under construction, boosting its US LNG exposure. Rio Grande LNG is expected to start production in 1H 2027 (first gas in 2H 2026).

$VGMedAI 8/10

12 Best LNG Stocks to Buy in 2026

The article says US LNG exports rose to a March record as plants ran above nameplate capacity and new units started up, with shipments to Asia more than doubling from February; it adds that nearly a quarter of US LNG went to Asia in April. It cites Europe’s shift away from Russian gas and China’s first US LNG shipments in over a year. It lists 12 LNG stocks ranked by hedge-fund holders, including Venture Global (Raymond James raises target to $16) and NextDecade (Citi starts at $11; Rio Grande t